UroGen Pharma (URGN) PT Lowered to $34 at Oppenheimer

March 19, 2021 10:20 AM EDT
Get Alerts URGN Hot Sheet
Price: $19.60 +4.70%

Rating Summary:
    7 Buy, 3 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 20 | Down: 24 | New: 32
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Oppenheimer analyst Leland Gershell lowered the price target on UroGen Pharma (NASDAQ: URGN) to $34.00 (from $40.00) while maintaining a Outperform rating.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change